Search - Prime Therapeutics
Navigate to
-
Certification recognizes quality service and continuous improvement
Prime Article: Press Releases -
Breadcrumb Home Careers Residency Program Join our residency program The ASHP-accredited Prime Therapeutics PGY1 residency program will allow you to build your best career in managed care. You will...
-
Help reimagine pharmacy We need the brightest and most passionate people to bring our purpose to life. Search open jobs Breadcrumb Home Careers Work + life in harmony Prime Therapeutics (Prime)...
-
Grant helps provide a home away from home for families facing cancer
PA Sub-Categories: Corporate responsibility Prime Article: Stories -
Prime is committed to simplifying the cancer care journey through leading oncology solutions designed to support people with cancer
Prime Article: Stories -
New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey
PA Sub-Categories: Corporate responsibility Prime Article: Stories -
How Prime Therapeutics/Magellan Rx Management reimagines pharmacy to do what's right.
Prime Article: Perspectives -
-
Our journey to reimagine pharmacy We are fueled by the desire to deliver an intuitive, meaningful, affordable experience that customers and members appreciate. By combining our innovation and...
-
-
At Pharmacy Benefit Management Institute (PBMI) annual conference, Prime received two awards: one for cost savings, another for leadership.
PA Sub-Categories: Awards Prime Article: Press Releases -
Develop a holistic GLP-1 strategy An evidence-based approach to GLP-1 drugs helps you implement custom strategies that promote clinically appropriate use and consider affordability, long-term value...
-
Tap into solutions that deliver real value The best Medicare and Managed Medicaid programs are ones that are customized to your needs and member population. Let us put our 40+ years of experience...
-
Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
-
Tap into our Expert Clinical Network Gain insights from leading key opinion leaders (KOLs) to drive better care. Breadcrumb Home Our solutions Specialty drug management Medical pharmacy Expert...
-
See our CSR efforts As outlined in our 2023 Corporate Social Responsibility Report, we're committed to creating sustainable social change, rallying around our common purpose. Read the report...
-
Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members
PA Sub-Categories: GLP-1 Prime Article: Perspectives -
Findings also show improved persistence with high-potency, obesity-approved GLP-1 products
PA Sub-Categories: GLP-1 Prime Article: Press Releases -
Build healthier communities By delivering affordable, reliable services that help improve health outcomes and coordinate care, we help you get your members the resources they need to live healthier...
-
Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Event features discussions about health care industry trends, best practices and innovations
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Hero headline Forward copy that anchors in the key themes of our campaign: we are an organization you can trust, with solutions built for every plan, and people who will work to do what is right...
-
Prime Therapeutics researchers share how the model helps to optimize drug therapy and lower costs
PA Sub-Categories: Technology Prime Article: Perspectives -
Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases -
-
Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024
Prime Article: Stories -
Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...
-
Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Culture Diversity,...
-
A look at the specialty landscape and how Prime delivers value to employers
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...
PA Sub-Categories: Specialty drugs Products Prime Article: Stories -
publications Pancreatic cancer: Innovative therapy approved, but unmet need continues April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth...
-
Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...
PA Sub-Categories: GLP-1 Technology Specialty drugs Products Prime Article: Perspectives -
Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point
Prime Article: Stories -
Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) High Cost Therapy Profile Gene Therapy/Immunology Marnetegragene autotemcel...
-
publications BiTEs and roadblocks June 25, 2025 Author: Simone Ndujiuba, PharmD, BCOP US Food and Drug Administration (FDA) has approved fourteen bispecific antibody drugs to treat a variety of...
-
Managed Markets Insight & Technology (MMIT)
PA Sub-Categories: Specialty drugs Products Prime Article: In the News -
Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.
PA Sub-Categories: GLP-1 Specialty drugs Products Prime Article: Press Releases -
Read Clinical News: August 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA SAFETY ALERT ON COMPOUNDED...